| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 6e-05 |